New Drugs

Brand/Generic Company Description
Balversa
erdafitinib
Click here for more information
Janssen

A kinase inhibitor for advanced or metastatic urothelial cancer.

Cablivi
caplacizumab-yhdp
Click here for more information
Ablynx U.S.

A von Willebrand factor-directed antibody fragment for treatment of acquired thrombotic thrombocytopenic purpura (aTTP).

Egaten
triclabendazole
Click here for more information
Novartis

An oral anthelmintic for treatment of fascioliasis.

Eticovo
etanercept-ykro
Click here for more information
Samsung Bioepis

A biosimilar to Enbrel.

Evenity
romosozumab-aqqg
Click here for more information
Amgen

A sclerostin inhibitor for treatment of postmenopausal osteoporosis in patients at high risk for fracture.

Herceptin Hylecta
trastuzumab/hyaluronidase-oysk
Click here for more information
Genentech

A subcutaneous injection formulation for HER2-overexpressing breast cancer.

Jeuveau
prabotulinumtoxin A-xvfs
Evolus

A botulinum toxin product to improve the appearance of frown lines between the eyebrows.

Mayzent
siponimod
Click here for more information
Novartis

An oral tablet formulation for relapsing forms of multiple sclerosis.

Ontruzant
trastuzumab-dttb
Merck

A biosimilar to Herceptin for breast cancer and gastric/gastroesophageal junction cancer.

Skyrizi
risankizumab-rzaa
Click here for more information
AbbVie

An interleukin-23 antagonist for moderate to severe plaque psoriasis.

Spravato
esketamine
Click here for more information
Janssen

An NMDA receptor antagonist nasal spray for treatment-resistant depression.

Sunosi
solriamfetol
Click here for more information
Jazz Pharm.

A dopamine and norepinephrine reuptake inhibitor (DNRI) for excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.

Trazimera
trastuzumab-qyyp
Click here for more information
Pfizer

A biosimilar to Herceptin for breast cancer and gastric/gastroesophageal junction cancer.

Zulresso
brexanolone
Click here for more information
Sage Therapeutics

An injectable medication for treatment of postpartum depression.

Brand/Generic Company Description
Adhansia XR
methylphenidate
Click here for more information
Purdue Pharma

New extended-release formulation for ADHD.

Avaclyr
acyclovir
Fera Pharm.

An ophthalmic ointment for acute herpetic keratitis.

Dovato
dolutegravir/lamivudine
ViiV Healthcare

New combination formulation for HIV-1 infection.

Duaklir Pressair
aclidinium/formoterol
Click here for more information
AstraZeneca

A combination anticholinergic and long-acting beta-agonist oral inhaler for COPD.

Duobrii
halobetasol propionate/tazarotene
Click here for more information
Bausch Health

New combination topical steroid/retinol lotion for plaque psoriasis.

Gloperba
colchicine
Click here for more information
Romeg Therapeutics

A new oral solution formulation for prevention of gout flares in adults.

Jatenzo
testosterone undecanoate
Click here for more information
Clarus Therapeutics

An oral androgen for testosterone replacement therapy.

Lotemax SM
loteprednol etabonate
Click here for more information
Bausch + Lomb

New 0.38% steroid ophthalmic gel formulation to improve absorption. For post-op inflammation/pain following ocular surgery.

Mavenclad
cladribine
Click here for more information
EMD Serono

New tablet formulation for treatment of relapsing forms of multiple sclerosis.

Qternmet XR
dapagliflozin/saxagliptin/metformin
Click here for more information
AstraZeneca

New combination product for type 2 diabetes.

Rocklatan
netarsudil/latanoprost
Click here for more information
Aerie Pharm.

New combination Rho kinase inhibitor and prostaglandin analogue to reduce intraocular pressure.

Tosymra
sumatriptan
Click here for more information
Promius Pharma

New 10 mg nasal spray formulation for acute migraine.

Zykadia
ceritinib
Click here for more information
Novartis

New tablet formulation for metastatic non-small cell lung cancer.

Brand/Generic Company Description